• From Bench to Bedside

    UMMS Licensing Revenue

    Ranked most recently at #14 in terms of licensing revenue in the U.S For FY 2015 ~ $32M and in 2006 -2015 ~ $395M


  • Three Graduate Schools

    The three UMMS graduate schools are the School of Medicine, the Graduate School of Biomedical Sciences and the Graduate School of Nursing with 1,300 faculty and only 1,100 graduate students.

    Read more
  • Research Awards

    FY 2014 ~ $244M & 3rd largest recipient of NIH funds among New England medical schools

    Read more
  • MassBiologics

    Fully-integrated developer of therapeutic biologics from discovery through GMP manufacturing.Only publicly-owned, FDA-licensed manufacturer of vaccines and other biologics in the U.S. Generated FY 2014 revenue of $41M

    Read more
  • Commonwealth Medicine

    UMMS’ healthcare consulting practice, generated FY 2014 revenue of $340M also Operates in 20 states and 27 countries.

    Read more

Welcome to the Office of Innovation & Business Development

Partnering Opportunities

The Office of Innovation and Business Development is responsible for developing and executing a comprehensive business strategy that promotes innovation, supports entrepreneurship, optimizes the institution’s research portfolio, and leverages the wide array of expertise and capabilities that exist throughout our academic community. 

Events

More Events

Headlines

Educational Recognition Awards, Last Lecture and Second Year Oath Ceremony will take place April 25

Educational Recognition Awards, Last Lecture and Second Year Oath Ceremony will take place April 25

David Hatem, MD, recipient of the 2016 Chancellor’s Medal for Distinguished Teaching, will deliver the Last Lecture on Tuesday, April 25, following the presentation of the 2017 Educational Recognition Awards. New this year, the event will include the Second Year Oath Ceremony for the School of Medicine Class of 2019.

Read more
▴ Back To Top
Section Menu To Top